Narcolepsy has long been known to be associated with specific Human Leukocyte Antigen variants, and therefore expected to be an autoimmune disorder. For many years, it proved difficult to detect evidence of such a process, but recent studies are making progress on genetic susceptibility factors, as well as potential environmental triggers. New results are also emerging on the presence of specific autoantibodies in the disorder, as well as phenotypic and potential pathophysiologic overlap with other autoimmune disorders. These results are the focus of this review
Human narcolepsy with cataplexy is a neurological disorder, which develops due to a deficiency in hy...
Narcolepsy with cataplexy, characterized by sleepiness and rapid onset into REM sleep, affects 1 in ...
Narcolepsy type 1 (NT1) is caused by a loss of hypocretin/orexin transmission. Risk factors include ...
Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness, cataplexy, hypn...
Recent advances in the identification of susceptibility genes and environmental exposures provide br...
a with disease rare a considered is narcolepsy, world suggesting, another to region one from varies ...
Recent advances in the identification of susceptibility genes and environmental exposures provide br...
Recent advances in the identification of susceptibility genes and environmental exposures provide br...
Type-1 narcolepsy is a severe neurological disorder with distinct characteristic of loss of hypocret...
The mechanisms involved in the autoimmune hypothesis of narcolepsy are investigated in this thesis. ...
Narcolepsy is a sleep disorder characterised by loss of hypothalamic hypocretin (orexin) neurons. Th...
Narcolepsy is a sleep disorder characterised by loss of hypothalamic hypocretin (orexin) neurons. Th...
Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness and cataplexy. T...
Narcolepsy with cataplexy is a debilitating sleep disorder with an estimated prevalence of about 0.0...
Narcolepsy is a chronic sleep disorder with a yet unknown cause, but the specific loss of hypocretin...
Human narcolepsy with cataplexy is a neurological disorder, which develops due to a deficiency in hy...
Narcolepsy with cataplexy, characterized by sleepiness and rapid onset into REM sleep, affects 1 in ...
Narcolepsy type 1 (NT1) is caused by a loss of hypocretin/orexin transmission. Risk factors include ...
Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness, cataplexy, hypn...
Recent advances in the identification of susceptibility genes and environmental exposures provide br...
a with disease rare a considered is narcolepsy, world suggesting, another to region one from varies ...
Recent advances in the identification of susceptibility genes and environmental exposures provide br...
Recent advances in the identification of susceptibility genes and environmental exposures provide br...
Type-1 narcolepsy is a severe neurological disorder with distinct characteristic of loss of hypocret...
The mechanisms involved in the autoimmune hypothesis of narcolepsy are investigated in this thesis. ...
Narcolepsy is a sleep disorder characterised by loss of hypothalamic hypocretin (orexin) neurons. Th...
Narcolepsy is a sleep disorder characterised by loss of hypothalamic hypocretin (orexin) neurons. Th...
Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness and cataplexy. T...
Narcolepsy with cataplexy is a debilitating sleep disorder with an estimated prevalence of about 0.0...
Narcolepsy is a chronic sleep disorder with a yet unknown cause, but the specific loss of hypocretin...
Human narcolepsy with cataplexy is a neurological disorder, which develops due to a deficiency in hy...
Narcolepsy with cataplexy, characterized by sleepiness and rapid onset into REM sleep, affects 1 in ...
Narcolepsy type 1 (NT1) is caused by a loss of hypocretin/orexin transmission. Risk factors include ...